Lesson 4.4 Complement Deficiencies and Assays
Complement Deficiencies and Complement Assays Notes
Learning Objectives
On completion of this session, students should be able to:
Understand how deficiencies in specific complement components disrupt immune responses and contribute to disease.
Learn the methods for diagnosing complement deficiencies, including laboratory tests.
Complement Deficiencies
Deficiencies in Classical Pathway Proteins
Involves proteins C1, C2, C4.
Leads to increased susceptibility to immune complex diseases.
Severity of Deficiencies
Varies according to the affected complement component.
C3 Deficiency
Associated with increased susceptibility to bacterial infections.
Terminal Pathway Protein Deficiencies
Involves proteins C5-C9.
Associated with increased susceptibility to Neisseria infections, specifically Neisseria meningitidis.
Deficiencies of Alternative Factor Proteins
These deficiencies are rare.
Complement Assays
Activity Assays
Measures complement hemolytic activity.
Classical Pathway CH50
Measures serum concentration required to lyse 50% of a red cell suspension.
Alternative Pathway CH50 (AH50)
Similar in principle to the classical pathway assay.
Variation in Methodology and Reference Ranges
It is essential to note that different laboratories may have varied methodologies leading to different reference ranges.
Measurement of Individual Components
C3, C4
Measured by nephelometry or turbidimetry.
Nephelometry Diagram:
Components include a light source, lens, scattering detector, and sample container.
C1, C2, C5-C9
Measured by radial immunodiffusion.
Diameter of the precipitate ring correlates with antigen concentration.
Summary of Complement Proteins
Antibody Binding:
C1q
Activating Enzymes:
C1r, C1s, C2b, Bb, D
Membrane Binding & Opsonins:
C4b, C3b
Peptide Mediators of Inflammation:
C3a, C4a, C5a
Membrane Attack Proteins:
C5b, C6, C7, C8, C9
Complement Receptors:
CR1, CR2, CR3, CR4
Regulatory Proteins:
C1 INH, C4bp, MCP, DAF, H I
Implications of Complement Deficiencies
Deficiencies in specific complement components can impair the immune system's ability to fight infections and regulate inflammation.
This can lead to an increased susceptibility to infections and autoimmune diseases.
Activity assays are crucial for measuring complement activation, which aids in identifying and managing these conditions effectively.